Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study
- PMID: 31388627
- PMCID: PMC6671685
- DOI: 10.1002/hep4.1392
Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study
Abstract
Nonalcoholic fatty liver disease (NAFLD) is one of the most common forms of liver disease worldwide and has emerged as a significant public health concern in China. A better understanding of the etiology of NAFLD can inform effective management strategies for this disease. We examined factors associated with NAFLD in two districts of Hangzhou, China, focusing on the relationship of regional body fat distribution, muscle mass, and NAFLD. We used baseline data to carry out a cross-sectional analysis among 3,589 participants from the Wellness Living Laboratory (WELL) China study, a longitudinal population-based study that aims to investigate and promote well-being among the Chinese population. NAFLD was defined using the widely validated fatty liver index (FLI). Multivariate logistic regressions were performed to assess independent associations between NAFLD and metabolic risk factors (e.g., insulin resistance) and dual x-ray absorptiometry (DXA)-derived measures (e.g., android fat ratio [AFR] and skeletal muscle index [SMI]). Of the 3,589 participants, 476 (13.3%) were classified as having FLI-defined NAFLD (FLI ≥60). Among those, 58.0% were men. According to our analysis, AFR (odds ratio [OR], 10.0; 95% confidence interval [CI], 5.8-18.5), insulin resistance (OR, 4.0; 95% CI, 3.0-5.3), high alanine aminotransferase levels (OR, 7.6; 95% CI, 5.8-10.0), smoking (OR, 2.0; 95% CI, 1.4-3.0), and male sex (OR, 2.9; 95% CI, 2.0-4.2) were positively associated with NAFLD risk, while SMI (OR, 0.1; 95% CI, 0.07-0.13) was inversely associated with NAFLD risk. Conclusion: In addition to known metabolic risk factors, DXA-derived AFR and SMI may provide additional insights to the understanding of NAFLD. Interventions that aim to decrease AFR and increase SMI may be important to reduce the burden of NAFLD in this population.
Figures
Similar articles
-
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10. J Bone Miner Res. 2019. PMID: 31074909 Free PMC article.
-
Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.Hepatobiliary Pancreat Dis Int. 2016 Feb;15(1):39-47. doi: 10.1016/s1499-3872(15)60030-3. Hepatobiliary Pancreat Dis Int. 2016. PMID: 26818542
-
Association of the android to gynoid fat ratio with nonalcoholic fatty liver disease: a cross-sectional study.Front Nutr. 2023 May 15;10:1162079. doi: 10.3389/fnut.2023.1162079. eCollection 2023. Front Nutr. 2023. PMID: 37255941 Free PMC article.
-
Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.Hepatology. 2014 May;59(5):1772-8. doi: 10.1002/hep.26716. Epub 2014 Mar 24. Hepatology. 2014. PMID: 23996808
-
Spotlight on Impactful Research: Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.Clin Liver Dis (Hoboken). 2020 Jun 30;15(6):213-214. doi: 10.1002/cld.914. eCollection 2020 Jun. Clin Liver Dis (Hoboken). 2020. PMID: 32617151 Free PMC article. Review.
Cited by
-
Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes.Obes Sci Pract. 2024 Jul 1;10(4):e777. doi: 10.1002/osp4.777. eCollection 2024 Aug. Obes Sci Pract. 2024. PMID: 38957476 Free PMC article.
-
Possible prediction of obesity-related liver disease in children and adolescents using indices of body composition.Pediatr Obes. 2022 Oct;17(10):e12947. doi: 10.1111/ijpo.12947. Epub 2022 Jun 21. Pediatr Obes. 2022. PMID: 35726748 Free PMC article.
-
Bioelectrical Impedance Analysis Can Be an Effective Tool for Screening Fatty Liver in Patients with Suspected Liver Disease.Healthcare (Basel). 2022 Nov 11;10(11):2268. doi: 10.3390/healthcare10112268. Healthcare (Basel). 2022. PMID: 36421592 Free PMC article.
-
"Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD".Obes Sci Pract. 2021 May 6;7(5):629-645. doi: 10.1002/osp4.509. eCollection 2021 Oct. Obes Sci Pract. 2021. PMID: 34631140 Free PMC article. Review.
-
Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-centre retrospective study.BMJ Open. 2023 Oct 30;13(10):e072489. doi: 10.1136/bmjopen-2023-072489. BMJ Open. 2023. PMID: 37903611 Free PMC article.
References
-
- Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11‐20. - PubMed
-
- Zhai HL, Wang NJ, Han B, Li Q, Chen Y, Zhu CF, et al. Low vitamin D levels and non‐alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross‐sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT‐China)). Br J Nutr 2016;115:1352‐1359. - PubMed
-
- Dietrich P, Hellerbrand C. Non‐alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol 2014;28:637‐653. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
